Stay updated with breaking news from Sam Gandy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Newly published safety data shows that 41 percent of patients in key clinical trials of the Alzheimer’s drug experienced brain bleeding or swelling, though many cases were asymptomatic.
Follow the StarTribune for the news, photos and videos from the Twin Cities and beyond.
Biogen research chief says 'misinformation' is cause for controversy surrounding newly approved Alzheimer's drug Dr Alfred Sandrock, head of research and development at Biogen, published a letter combatting 'misinformation' surrounding its drug, Aduhelm He says that debate over whether the drug works is normal after FDA accelerated approval Cleveland Clinic and Mount Sinai both said they will not administer the controversial drug to patients Aduhelm received FDA approval last month despite little evidence that it worked in clinical trials Drug will cost an individual $56,000 for a year of ...
Filed to:aducanumab alzheimers diseasebiogenclinical trialfederal assistance in the united statesfood and drug administrationhealth medical pharmahealthcare reform in the united statesjanet woodcockkaiser family foundationkatie porterlife sciencesmedicaidmedicarepresidency of lyndon b johnsonsam gandythe centers for medicare and medicaid services Photo: Matthew Simmons, Getty Images Parts of the medical world are continuing to rebel against Aduhelm, the controversial treatment developed by Biogen and recently approved for Alzheimer’s disease by the U.S. Food and Drug Administration. This we...
Mass General Brigham unlikely to recommend Alzheimer’s drug to patients on blood thinners Jonathan Saltzman © Provided by The Boston Globe More than a third of patients who took Aduhelm in clinical trials had small brain bleeds or an accumulation of fluid detected by MRI. Mass General Brigham is unlikely to offer Biogen’s controversial new Alzheimer’s drug to patients taking blood thinners because of concerns about the risk of bleeding in the brain, according to two doctors helping to develop a policy on the medicine for the state’s largest health care provider. Dr....